Riskpilot← Back to searchSign inGet full accessVICTORYKLINIKERNA AB
ABActiveOrg 5566234380Rålambsvägen 18Other human health activities n.e.c. · NACE 8699Est. 20021 employees
Revenue 2024
SEK 87K
+13% vs 2023
EBITDA margin
-48.3%
-950% vs 2023
Equity ratio
95.8%
Financial strength
Net profit 2024
SEK -42K
-950% vs 2023
| Revenue | SEK 87K | +13% |
| EBITDA | SEK -42K | -950% |
| Net profit | SEK -42K | -950% |
| Total assets | SEK 165K | -22% |
| Equity | SEK 158K | -21% |
| Employees | 1 | — |
Legal name
VICTORYKLINIKERNA AB
Org number
5566234380
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
7 februari 2002
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolagets verksamhet omfattar medicinsk och hälsoinriktad verksamhet vänd till allmänheten, företag, organisationer och myndigheter, kliniska prövningar och patentutveckling. Bolaget ska vidare bedriva utbildnings- och förlagsverksamhet samt fastighetsförvaltning och handel med värdepapper.
Address
Rålambsvägen 18
Phone
+4687046650
Email
mikaelholstki@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 78 | 100 | 68 | 77 | 87 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 61 | 61 | 39 | −4 | −42 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 61 | 61 | 39 | −4 | −42 |
| Net financials | — | — | — | — | — |
| Profit before tax | 61 | 61 | 39 | −4 | −42 |
| Tax | −4 | −13 | −8 | −0 | −0 |
| Net profit | 57 | 48 | 31 | −4 | −42 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 145 | 206 | 235 | 211 | 165 |
| Equity | 125 | 173 | 204 | 200 | 158 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 20 | 33 | 30 | 11 | 7 |
| Total debt | 20 | 33 | 30 | 11 | 7 |
EBITDA margin
-48.3%
This company
15.8%
Market median
-406% vs market
20202024
Equity ratio
95.8%
This company
38.2%
Market median
+151% vs market
20202024
Return on equity
-26.6%
This company
18.4%
Market median
-245% vs market
20202024
Net profit margin
-48.3%
This company
8.1%
Market median
-696% vs market
20202024
Asset turnover
0.53×
This company
1.12×
Market median
-53% vs market
20202024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SO Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of VICTORYKLINIKERNA AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sixten Olof Söder | Chief Executive Officer | 0 companies |
| Mikael John Stefan Holst | Board of Directors | 0 companies |
| Anna Karolina Söder | Board of Directors | 0 companies |
| Per Martin Hellström | Chairman | 0 companies |